Study design, patient eligibility and treatment This was a phase 1, first-in-human, open-label, nonrandomized, dose-escalation ...
Gatto, M., Zen, M., Cruciani, C., Iaccarino, L. & Doria, A. Navigating the landscape of ...
Competing interests M.S.v.d.H. has received institutional funding from Bristol Myers Squibb to finance the INDIBLADE ...
Study design and treatments Approval Human subject work was performed in accordance with an approved ...
Study design For this randomized, open-label, single-centre, phase 2 trial, patients were enrolled at the ...
Bartholomeeusen, K. et al. Chikungunya fever. Nat. Rev. Dis. Primers 9, 17 (2023). Article PubMed ...
Trial participants Our study population comprised individuals aged 18 years or older with a diagnosis of ...
Oversight The MG-001 part 3 trial was performed in accordance with the principles of the ...
Preclinical in vitro experiments Generation of CAR cells and evaluation of CAR expression Primary CD8+ ...